Webinar: Use of Serum and Imaging Biomarkers of NAFLD/NASH in Clinical Practice

When:  Feb 17, 2021 from 12:00 PM to 1:00 PM (ET)


Nonalcoholic Fatty Liver Disease SIG


  • Emmanuel A. Tsochatzis MD, PhD, MSc, FEBTM, FRCP
  • Mohammad Shadab Siddiqui, MD
  • Alina Allen, MD


  • Kathleen E. Corey, MD, MPH, MMSc


This live webinar will update the audience on the most recent data in non-invasive testing (NITs) biomarkers in NAFLD/NASH (including use for staging, monitoring disease progression and response to therapy). We will focus on three key areas: serum-based biomarkers, imaging-based biomarkers and how to use combination or sequential NITs. At the conclusion of the webinar, learners will have an update on knowledge of various biomarkers in NAFLD and a path to apply best practices in their setting.


AASLD is grateful to AbbVie for its generous sponsorship of AASLD Webinars